Evolution of living donor liver transplantation over 10 years: experience of a single center

Surg Today. 2008;38(9):795-800. doi: 10.1007/s00595-007-3729-8. Epub 2008 Aug 28.

Abstract

Purpose: To evaluate the changes in living donor liver transplantations (LDLTs) over the last 10 years, we analyzed our experience of performing LDLT in a single center.

Methods: We performed 73 LDLTs over the 10 years between 1997 and 2007 in Nagasaki University Hospital, Japan.

Results: Initially, from 1997 to 2003, LDLT was performed for pediatric patients; then, between 2004 and 2007, adult-to-adult LDLT was introduced, primarily for hepatocellular carcinoma (HCC) in liver cirrhosis. We also began performing LDLTs for adults with ABO-incompatible blood type combination in the latter period. As the number of adult-to-adult LDLTs increased, left-sided grafts became fi rst choice for these patients. Survival rates were 88.3%, 77.2%, 70.2% at 1, 3, and 5 years, respectively. There was a relatively low incidence of arterial complications, and although the incidence of biliary complications was high initially, it decreased with experience. Likewise, the operative time, blood loss, and hospital stay after LDLT also improved remarkably.

Conclusion: Over the last 10 years the indications for, and operative techniques used in LDLT have changed dramatically, even in a single center in Japan.

MeSH terms

  • ABO Blood-Group System
  • Adolescent
  • Adult
  • Aged
  • Blood Group Incompatibility
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / surgery*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Liver Cirrhosis / complications
  • Liver Neoplasms / complications
  • Liver Neoplasms / surgery*
  • Liver Transplantation* / adverse effects
  • Living Donors*
  • Male
  • Middle Aged
  • Young Adult

Substances

  • ABO Blood-Group System